<?xml version="1.0" encoding="UTF-8"?>
<mods xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.1" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
  <titleInfo>
    <title>Private versus public sector insurance coverage for drug abuse</title>
  </titleInfo>
  <name type="personal">
    <namePart>Rogowski, Jeannette A.</namePart>
    <role>
      <roleTerm authority="marcrelator" type="text">creator</roleTerm>
    </role>
    <role>
      <roleTerm type="text">author.</roleTerm>
    </role>
  </name>
  <name type="corporate">
    <namePart>RAND Drug Policy Research Center</namePart>
  </name>
  <name type="corporate">
    <namePart>Ford Foundation</namePart>
  </name>
  <name type="corporate">
    <namePart>Weingart Foundation</namePart>
  </name>
  <typeOfResource>text</typeOfResource>
  <genre authority="marc">bibliography</genre>
  <originInfo>
    <place>
      <placeTerm type="code" authority="marccountry">cau</placeTerm>
    </place>
    <dateIssued encoding="marc">1993</dateIssued>
    <issuance>monographic</issuance>
  </originInfo>
  <language>
    <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
  </language>
  <physicalDescription>
    <form authority="marcform">print</form>
    <extent>xi, 53 pages : illustrations ; 28 cm</extent>
  </physicalDescription>
  <abstract>This study examined financing mechanisms currently in place for treating drug abuse, focusing primarily on differences between private and public insurance mechanisms. Within the private sector, insurance coverage for drug abuse treatment is quite restrictive. Limitations typically exist on the type and amount of treatment that can be received per year or per lifetime, and benefits may quickly be exhausted. Limitations also exist with regard to public insurance funding. Eligibility requirements and the authorized settings in which care may be provided are extremely restrictive. It has been argued that public funding for drug abuse should be mainstreamed into Medicaid. However, this is not likely to occur due to significant institutional barriers, and in particular to the highly restrictive eligibility requirements for public programs.</abstract>
  <note type="statement of responsibility">Jeannette A. Rogowski.</note>
  <note>"Drug Policy Research Center."</note>
  <note>Includes bibliographical references (p. 51-53).</note>
  <note>Also available on the internet via WWW in PDF format.</note>
  <subject>
    <geographicCode authority="marcgac">n-us---</geographicCode>
  </subject>
  <subject authority="lcsh">
    <name type="corporate">
      <namePart>United States.</namePart>
      <namePart>Office of Civilian Health and Medical Program of the Uniformed Services.</namePart>
    </name>
  </subject>
  <subject authority="lcsh">
    <topic>Drug abuse</topic>
    <topic>Treatment</topic>
    <geographic>United States</geographic>
    <topic>Finance</topic>
  </subject>
  <subject authority="lcsh">
    <topic>Insurance, Health</topic>
    <geographic>United States</geographic>
  </subject>
  <subject authority="lcsh">
    <topic>Medicaid</topic>
  </subject>
  <subject authority="lcsh">
    <topic>Medicare</topic>
  </subject>
  <classification authority="lcc">HD7102.U4 R554</classification>
  <identifier type="isbn">0833013459</identifier>
  <identifier type="lccn">93012592</identifier>
  <identifier type="stock number"/>
  <identifier type="uri"> http://www.rand.org/pubs/monograph_reports/2006/MR166.pdf</identifier>
  <location>
    <url displayLabel="Online Access"> http://www.rand.org/pubs/monograph_reports/2006/MR166.pdf</url>
  </location>
  <recordInfo>
    <recordContentSource authority="marcorg">CstmoR</recordContentSource>
    <recordCreationDate encoding="marc">930407</recordCreationDate>
    <recordIdentifier source="RAND">rnd000000000111884</recordIdentifier>
  </recordInfo>
</mods>
